These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1284458)
1. Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties. Jackisch R; Link T; Neufang B; Koch R Arch Int Pharmacodyn Ther; 1992; 320():21-42. PubMed ID: 1284458 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. Lupp A; Lücking CH; Koch R; Jackisch R; Feuerstein TJ J Pharmacol Exp Ther; 1992 Nov; 263(2):717-24. PubMed ID: 1359111 [TBL] [Abstract][Full Text] [Related]
4. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro. Jackisch R; Huang HY; Reimann W; Limberger N J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757 [TBL] [Abstract][Full Text] [Related]
5. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. Kamal LA; Arbilla S; Galzin AM; Langer SZ J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724 [TBL] [Abstract][Full Text] [Related]
6. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
7. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
8. Effects of urapidil on neurotransmitter release in CNS tissue in vitro. Jackisch R; Kasakov L; Feuerstein TJ; Hertting G Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):5-24. PubMed ID: 2883943 [TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Peeters M; Romieu P; Maurice T; Su TP; Maloteaux JM; Hermans E Eur J Neurosci; 2004 Apr; 19(8):2212-20. PubMed ID: 15090047 [TBL] [Abstract][Full Text] [Related]
11. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta. Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164 [TBL] [Abstract][Full Text] [Related]
12. In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat. Clement HW; Grote C; Svensson L; Engel J; Zöfel P; Wesemann W J Neural Transm Suppl; 1995; 46():107-15. PubMed ID: 8821046 [TBL] [Abstract][Full Text] [Related]
13. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1985 Feb; 232(2):492-500. PubMed ID: 3155797 [TBL] [Abstract][Full Text] [Related]
14. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. Quack G; Hesselink M; Danysz W; Spanagel R J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045 [TBL] [Abstract][Full Text] [Related]
15. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis. Feuerstein TJ; Hedler L; Jackisch R; Hertting G Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882 [TBL] [Abstract][Full Text] [Related]
16. Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors. Jin S; Fredholm BB Br J Pharmacol; 1997 Aug; 121(7):1269-76. PubMed ID: 9257903 [TBL] [Abstract][Full Text] [Related]
17. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Feuerstein TJ; Hertting G; Lupp A; Neufang B Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155 [TBL] [Abstract][Full Text] [Related]
18. Effects of verapamil, diltiazem and ryosidine on the release of dopamine and acetylcholine in rabbit caudate nucleus slices. Starke K; Späth L; Wichmann T Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):124-30. PubMed ID: 6144047 [TBL] [Abstract][Full Text] [Related]
19. Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices. Bowyer JF; Scallet AC; Holson RR; Lipe GW; Slikker W; Ali SF J Pharmacol Exp Ther; 1991 Apr; 257(1):262-70. PubMed ID: 1673475 [TBL] [Abstract][Full Text] [Related]
20. Trapping channel block of NMDA-activated responses by amantadine and memantine. Blanpied TA; Boeckman FA; Aizenman E; Johnson JW J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]